Last reviewed · How we verify
Experimental: Low dose LABTHERA-001 capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Experimental: Low dose LABTHERA-001 capsule (Experimental: Low dose LABTHERA-001 capsule) — AtoGen Co. Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Experimental: Low dose LABTHERA-001 capsule TARGET | Experimental: Low dose LABTHERA-001 capsule | AtoGen Co. Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Experimental: Low dose LABTHERA-001 capsule CI watch — RSS
- Experimental: Low dose LABTHERA-001 capsule CI watch — Atom
- Experimental: Low dose LABTHERA-001 capsule CI watch — JSON
- Experimental: Low dose LABTHERA-001 capsule alone — RSS
Cite this brief
Drug Landscape (2026). Experimental: Low dose LABTHERA-001 capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/experimental-low-dose-labthera-001-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab